US hospital database analysis of invasive aspergillosis in the chronic obstructive pulmonary disease non-traditional host

Journal of Medical Economics

Volumn 14, Issue 2, 2011, Pages 227-237

  Patel, Dipen A ^a   Gao, Xin ^a   Stephens, Jennifer M ^a   Forshag, Mark S ^b   Tarallo, Miriam ^b,c  

^a PHARMERIT INTERNATIONAL   (United States)

^b PFIZER INC   (United States)

^c Global Outcomes Research   (Italy)

Author keywords

Antifungals; Chronic obstructive pulmonary disease; Hospital database analysis; Invasive aspergillosis; Non traditional host; Outcomes; Resource utilization

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; DEXAMETHASONE; ECHINOCANDIN; FLUCONAZOLE; HYDROCORTISONE; ITRACONAZOLE; MEPREDNISONE; MICAFUNGIN; POSACONAZOLE; PREDNISOLONE; VORICONAZOLE;

ADULT; AGED; ALGORITHM; ANTIFUNGAL THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DATA BASE; DISEASE SEVERITY; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HUMAN; INTENSIVE CARE UNIT; INVASIVE ASPERGILLOSIS; LENGTH OF STAY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING; UNITED STATES;

AGED; ANTIFUNGAL AGENTS; CASE-CONTROL STUDIES; DATABASES, FACTUAL; FEMALE; HEALTH STATUS INDICATORS; HOSPITALIZATION; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; LENGTH OF STAY; MALE; MULTIVARIATE ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 79953017113     PISSN: 13696998     EISSN: None     Source Type: Journal    
DOI: 10.3111/13696998.2011.564246     Document Type: Article

References (20)

1. Steinbach WJ, Stevens DA, Denning DW, et al. Advances against aspergillo-sis. Clin Infect Dis 2003;37(Suppl 3):S155-6
2. Ader F, Nseir S, Le Berre R, et al. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect2005;11:427-9 (Pubitemid 40744388)
3. McEvoy CE, Niewoehner DE. Adverse effects of corticosteroid therapy for COPD.Acritical review. Chest1997;111:732-43 (Pubitemid 27132953)
4. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46:327-60 (Pubitemid 351265310)
5. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001;32:358-66 (Pubitemid 32173620)
6. Rodrigues J, Niederman MS, Fein AM, et al. Nonresolving pneumonia in steroid-treated patients with obstructive lung disease. Am J Med 1992; 93:29-34
7. Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 2007;30:782-800 (Pubitemid 351194841)
8. Bulpa PA, Dive AM, Garrino MG, et al. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care? Intensive. Care Med 2001;27:59-67 (Pubitemid 32208970)
9. FranquetT, MullerNL, GimenezA, et al. Semiinvasivepulmonaryaspergillosis in chronic obstructive pulmonary disease: radiologic and pathologic findings in nine patients. AJR Am J Roentgenol 2000;174:51-6
10. Chandwani S, Wentworth C, Burke TA, et al. Utilization and dosage pattern of echinocandins for treatment of fungal infections in US hospital practice. Curr Med Res Opin 2009;25:385-93
11. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol1992;45:613-19
12. Charlson ME, Pompei P, Ales KL, et al. Anewmethod of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83 (Pubitemid 17055592)
13. RxList-WebMD, 2009. Antifungal dosage and administration. Available at www.rxlist.com [Last accessed 30 June 2009]
14. Dimopoulos G, Piagnerelli M, Berre J, et al. Disseminated aspergillosis in intensive care unit patients: an autopsy study. J Chemother 2003;15:71-5 (Pubitemid 36349895)
15. Groll AH, Shah PM, Mentzel C, et al. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996;33:23-32 (Pubitemid 26289847)
16. Meersseman W, Lagrou K, Maertens J, et al. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007;45:205-16 (Pubitemid 47044802)
17. Klont RR, Meis JF, Verweij PE. Critical assessment of issues in the diagnosis of invasive aspergillosis. Clin Microbiol Infect2001;7(Suppl 2):32-7
18. Rello J, Esandi ME, Mariscal D, et al. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 1998;26:1473-5 (Pubitemid 28270191)
19. von Eiff M, Roos N, Schulten R, et al. Pulmonaryaspergillosis: earlydiagnosis improves survival. Respiration 1995;62:341-7
20. Chang D, Burwell L, Lyon G, et al. Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis. Infect Control Hosp Epidemiol 2008; 29:25-30 (Pubitemid 351267770)